Advertisement

Clinical responses and persistent BRAFV600E+ blood cells in children with LCH treated with MAPK pathway inhibition

Olive S. Eckstein, Johannes Visser, Carlos Rodriguez-Galindo and Carl E. Allen
PDF extract preview

This is a PDF-only article. The first page of the PDF of this article appears above.